Zydus Cadila

Bhubaneswar: India's drug regulator on Friday approved Zydus Cadila's India-developed anti-Covid jab ZyCoV-D for emergency use in adults and children aged 12 years and above. The Centre is yet to issue guidelines in this regard, said…
Read More...

New Delhi: The approval for Zydus Cadila's indigenous ZyCov-D, the world's first DNA-based vaccine, is a testimony to the innovative zeal of India's scientists, Prime Minister Narendra Modi said. "India is fighting COVID-19 with full…
Read More...

New Delhi: Zydus Cadila's three-dose indigenous Covid-19 vaccine ZyCoV-D, the world's first DNA-based Covid vaccine that can be administered to people aged 12 and above, on Friday received emergency use authorisation (EUA) in India, an…
Read More...

New Delhi: Indian drugmaker Zydus Cadila has applied to the Drugs Controller General of India (DCGI) on Thursday for emergency use approval of its COVID-19 vaccine. Reportedly, the company conducted the clinical trial for its COVID-19…
Read More...

New-Delhi: Zydus Cadilla on Wednesday has sought permission from the Drug Controller General of India (DCGI) to undertake human testing of its novel monoclonal antibody cocktail that can neutralise COVID-19 infection. ZRC-3308 is a…
Read More...

Gandhinagar: Prime Minister Narendra Modi began his three-city vaccine tour on Saturday starting with pharma major Zydus Cadila's plant in Gujarat to review the development of the much-awaited coronavirus inoculation and its manufacturing…
Read More...